US EditionNvidia, Eli Lilly Commit $1B to AI Drug Discovery Lab
The five-year, $1 billion partnership aims to produce large-scale 'ground truth' data and apply AI across Eli Lilly's drug discovery and clinical development processes.
- At the J.P. Morgan Healthcare Conference on Jan. 12, 2026, NVIDIA and Eli Lilly and Company unveiled a first-of-its-kind AI co-innovation lab with a five-year collaboration investing $1 billion.
- Building on Lilly's October supercomputer plan, the lab expands Lilly's AI factory using NVIDIA Vera Rubin to produce large-scale lab-generated ground truth data for biology foundation models.
- The new Bay Area site in South San Francisco will open by the end of March, with work expected to begin early this year using NVIDIA BioNeMo, Vera Rubin architecture, and DGX platforms.
- The partners will build a continuous learning system linking Lilly's agentic wet labs with computational dry labs to enable 24/7 AI-assisted experimentation and apply AI across manufacturing and commercial operations, raising expectations for shorter discovery cycles and more viable clinical candidates that pharma investors care about.
- Analysts estimate the technology's market-scale impact, noting AI could deliver $868 billion in healthcare by 2030, but biology's complexity and FDA scrutiny require automation and robotics to earn scientists' trust.
17 Articles
17 Articles
Nvidia Deepens Push Into Drug Discovery Via New Partnerships with Lilly, Thermo Fisher & More
At JPM, Nvidia unveiled partnerships with Eli Lilly, Thermo Fisher and others that show how the chipmaker is pushing its AI beyond models and into the core infrastructure of drug discovery and research labs. The moves highlight Nvidia’s ambitions to become a foundational technology provider for the pharma industry.
Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma's Future
Quick Read Eli Lilly (LLY) and Nvidia (NVDA) will invest up to $1B over five years in an AI drug discovery lab. AI could reduce pharma R&D costs by 30% to 40% and shorten timelines by one to four years. The partnership expands Lilly’s existing AI supercomputer project with Nvidia’s DGX technology. It sounds nuts, but SoFi is giving new active invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get star…
Many companies see the future in artificial intelligence. With its high-tech chips, Nvidia often provides the foundation stone for this. Now the company is taking a big step together with the weight loss manufacturer Eli Lilly.
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
